NAMSW icon

NewAmsterdam Pharma Warrant
NAMSW

9 hedge funds and large institutions have $29.9M invested in NewAmsterdam Pharma Warrant in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.73M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$390K

Top Sellers

1
-$285K
2
-$6.2K
3
-$2.88K
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$25
Name Holding Trade Value Shares
Change 		Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$11.5M
RCM
2
RA Capital Management
Massachusetts
$7.67M
AAA
3
Affinity Asset Advisors
New York
$5.63M
BCLSI
4
Bain Capital Life Sciences Investors
Massachusetts
$2.3M
DM
5
Deerfield Management
New York
$2.13M
AC
6
Aristeia Capital
Connecticut
$397K
VI
7
Vestcor Inc
New Brunswick, Canada
$239K
CIBC Private Wealth Group
8
CIBC Private Wealth Group
Georgia
$25.3K
UBS Group
9
UBS Group
Switzerland
$9.27K
LCM
10
Laurion Capital Management
New York
–